Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Alzheimer's Disease Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Donepezil
  • 1.3.3 Memantine
  • 1.3.4 Rivastigmine
• 1.4 Market Segment by Application
  • 1.4.1 Global Alzheimer's Disease Market Share by Application (2019-2025)
  • 1.4.2 Early to Moderate Stages
  • 1.4.3 Moderate to Severe Stages
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Alzheimer's Disease Market Size
  • 2.1.1 Global Alzheimer's Disease Revenue 2014-2025
  • 2.1.2 Global Alzheimer's Disease Sales 2014-2025
• 2.2 Alzheimer's Disease Growth Rate by Regions
  • 2.2.1 Global Alzheimer's Disease Sales by Regions 2014-2019
  • 2.2.2 Global Alzheimer's Disease Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Alzheimer's Disease Sales by Manufacturers
  • 3.1.1 Alzheimer's Disease Sales by Manufacturers 2014-2019
  • 3.1.2 Alzheimer's Disease Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Alzheimer's Disease Revenue by Manufacturers (2014-2019)
  • 3.2.2 Alzheimer's Disease Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Alzheimer's Disease Market Concentration Ratio (CR5 and HHI)
• 3.3 Alzheimer's Disease Price by Manufacturers
• 3.4 Key Manufacturers Alzheimer's Disease Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Alzheimer's Disease Market
• 3.6 Key Manufacturers Alzheimer's Disease Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Donepezil Sales and Revenue (2014-2019)
  • 4.1.2 Memantine Sales and Revenue (2014-2019)
  • 4.1.3 Rivastigmine Sales and Revenue (2014-2019)
• 4.2 Global Alzheimer's Disease Sales Market Share by Type
• 4.3 Global Alzheimer's Disease Revenue Market Share by Type
• 4.4 Alzheimer's Disease Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Alzheimer's Disease Sales by Application

6 United States

• 6.1 United States Alzheimer's Disease Breakdown Data by Company
• 6.2 United States Alzheimer's Disease Breakdown Data by Type
• 6.3 United States Alzheimer's Disease Breakdown Data by Application

7 European Union

• 7.1 European Union Alzheimer's Disease Breakdown Data by Company
• 7.2 European Union Alzheimer's Disease Breakdown Data by Type
• 7.3 European Union Alzheimer's Disease Breakdown Data by Application

8 China

• 8.1 China Alzheimer's Disease Breakdown Data by Company
• 8.2 China Alzheimer's Disease Breakdown Data by Type
• 8.3 China Alzheimer's Disease Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Alzheimer's Disease Breakdown Data by Company
• 9.2 Rest of World Alzheimer's Disease Breakdown Data by Type
• 9.3 Rest of World Alzheimer's Disease Breakdown Data by Application
• 9.4 Rest of World Alzheimer's Disease Breakdown Data by Countries
  • 9.4.1 Rest of World Alzheimer's Disease Sales by Countries
  • 9.4.2 Rest of World Alzheimer's Disease Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Allergan
  • 10.1.1 Allergan Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Alzheimer's Disease
  • 10.1.4 Alzheimer's Disease Product Introduction
  • 10.1.5 Allergan Recent Development
• 10.2 Eisai
  • 10.2.1 Eisai Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Alzheimer's Disease
  • 10.2.4 Alzheimer's Disease Product Introduction
  • 10.2.5 Eisai Recent Development
• 10.3 Novartis
  • 10.3.1 Novartis Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Alzheimer's Disease
  • 10.3.4 Alzheimer's Disease Product Introduction
  • 10.3.5 Novartis Recent Development
• 10.4 Daiichi Sankyo
  • 10.4.1 Daiichi Sankyo Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Alzheimer's Disease
  • 10.4.4 Alzheimer's Disease Product Introduction
  • 10.4.5 Daiichi Sankyo Recent Development
• 10.5 Merz Pharma
  • 10.5.1 Merz Pharma Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Alzheimer's Disease
  • 10.5.4 Alzheimer's Disease Product Introduction
  • 10.5.5 Merz Pharma Recent Development
• 10.6 Pfizer
  • 10.6.1 Pfizer Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Alzheimer's Disease
  • 10.6.4 Alzheimer's Disease Product Introduction
  • 10.6.5 Pfizer Recent Development
• 10.7 Johnson & Johnson
  • 10.7.1 Johnson & Johnson Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Alzheimer's Disease
  • 10.7.4 Alzheimer's Disease Product Introduction
  • 10.7.5 Johnson & Johnson Recent Development
• 10.8 Lundbeck
  • 10.8.1 Lundbeck Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Alzheimer's Disease
  • 10.8.4 Alzheimer's Disease Product Introduction
  • 10.8.5 Lundbeck Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Alzheimer's Disease Sales Channels
  • 11.2.2 Alzheimer's Disease Distributors
• 11.3 Alzheimer's Disease Customers

12 Market Forecast

• 12.1 Global Alzheimer's Disease Sales and Revenue Forecast 2019-2025
• 12.2 Global Alzheimer's Disease Sales Forecast by Type
• 12.3 Global Alzheimer's Disease Sales Forecast by Application
• 12.4 Alzheimer's Disease Forecast by Regions
  • 12.4.1 Global Alzheimer's Disease Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Alzheimer's Disease Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

Alzheimer's disease is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60–70% of cases of dementia. The most common early symptom is difficulty in remembering recent events (short-term memory loss).
In 2019, the market size of Alzheimer's Disease is 2900 million US$ and it will reach 10500 million US$ in 2025, growing at a CAGR of 17.5% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Alzheimer's Disease.

This report studies the global market size of Alzheimer's Disease, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Alzheimer's Disease sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
Lundbeck

Market Segment by Product Type
Donepezil
Memantine
Rivastigmine

Market Segment by Application
Early to Moderate Stages
Moderate to Severe Stages

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Alzheimer's Disease status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Alzheimer's Disease manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Alzheimer's Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025